The ECFS welcomes the approval of Vertex’s KALYDECO (ivacaftor) by the FDA.
Press release available here (external site)
Update from May 25, 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO™...Read more
4 workshops open to external participants included in a pilot PhD programme on: "Molecular and Cellular Biology of the Epithelium in Health and Disease at the University of Lisbon".
Award Winners at the 8th Basic Science Conference held in Tirrenia, Italy 30 March - 2 April 2011
The ECFS thanks the Chairpersons of the 8th Basic Science Conference:...Read more
Young Investigator Awards and Travel Grants
The Scientific Committee of the 34th ECFS Conference has, as part of the abstract review process, selected the abstracts they have deemed...Read more
A message from the ECFS President and the Director of the ECFS Clinical Trials Network
The recent trial of VX770 in patients with G551D mutations has reported its...Read more
On the 19th June 2010, as part of the closing ceremony of the 33rd European Cystic Fibrosis conference in Valencia, the European Cystic Fibrosis Society was presented a cheque of...Read more
In conjunction with the 33rd ECFS Conference in Valencia, the following awards were presented..
Prof. Margarida Amaral and Dr. David Sheppard
The 2010 ECFS Award was...Read more
Basic Science Conference 15-19 April 2009, Tavira, Portugal - Report from the Chairpersons
Michael Gray, Newcastle University, UK
Mitchell Drumm, Case Western Reserve University, USA